Stifel Nicolaus analyst Jonathan Block maintained a Buy rating on DENTSPLY SIRONA (NASDAQ:XRAY) Inc on Sunday, setting a price target of $52, which is approximately 3.56% below the present share price of $53.92.
Block expects DENTSPLY SIRONA Inc to post earnings per share (EPS) of $0.25 for the first quarter of 2021.
The current consensus among 11 TipRanks analysts is for a Moderate Buy rating of shares in DENTSPLY SIRONA, with an average price target of $57.3.
The analysts price targets range from a high of $71 to a low of $44.
In its latest earnings report, released on 09/30/2020, the company reported a quarterly revenue of $894.8 million and a net profit of $100.4 million. The company's market cap is $11.78 billion.
According to TipRanks.com, Stifel Nicolaus analyst Jonathan Block is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 20.6% and a 68.97% success rate.
DENTSPLY SIRONA, Inc. engages in the design, manufacture, sales, and distribution of professional dental products and technologies. It operates through the Technologies and Equipment, and Consumables segments. The Technologies and Equipment segments comprises dental technology, equipment, and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers, and consumable medical device products. The Consumables segment offers preventive, restorative, instruments, endodontic, and orthodontic dental products. The company was founded in 2016 and is headquartered in York, PA.